Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-5-21
|
pubmed:abstractText |
We performed two studies to determine whether the lipid-lowering effect of viscous soluble fiber was modified by monounsaturated fatty acid (MUFA). First, psyllium (1.4 g/MJ) was compared with wheat bran (control) in 1-mo metabolic diets by using a randomized crossover design (n = 32 hyperlipidemic subjects). The background diet contained approximately 6% of energy as MUFA (20% of total fat). The second study (n = 27 hyperlipidemic subjects) was similar to the first but the background diet contained approximately 12% MUFA (29% of total fat) because of the addition of canola oil. At both fat intakes, psyllium resulted in significant reductions in total, low-density-lipoprotein (LDL), and high-density-lipoprotein (HDL) cholesterol compared with the wheat bran control. For the psyllium diet at 6% compared with 12% MUFA, the decreases in LDL cholesterol were 12.3 +/- 1.5% (P < 0.001) and 15.3 +/- 2.4% (P < 0.001), respectively. With the higher-MUFA diet triacylglycerol fell significantly over the control phase (16.6 +/- 5.5%, P = 0.006) and the ratio of LDL to HDL cholesterol fell significantly over the psyllium phase (7.3 +/- 2.8%, P = 0.015). Psyllium and MUFA intakes were negatively related to the percentage change in the ratio of LDL to HDL cholesterol (r = -0.34, P = 0.019 and r = -0.44, P = 0.002, respectively). Chenodeoxycholate synthesis rate increased (30 +/- 13%, P = 0.038) with the psyllium diet in the 12 subjects in whom this was assessed. We conclude that psyllium lowered LDL- and HDL-cholesterol concentrations similarly at both MUFA intakes. However, there may be some advantage in combining soluble fiber and MUFA to reduce the ratio of LDL to HDL cholesterol.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Bile Acids and Salts,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats, Unsaturated,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated,
http://linkedlifedata.com/resource/pubmed/chemical/Psyllium
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0002-9165
|
pubmed:author |
pubmed-author:ConnellyP WPW,
pubmed-author:CoreyP NPN,
pubmed-author:CunnaneS CSC,
pubmed-author:FulgoniVV3rd,
pubmed-author:GarveyM BMB,
pubmed-author:JenkinsD JDJ,
pubmed-author:KüttelPP,
pubmed-author:KendallC WCW,
pubmed-author:LawJJ,
pubmed-author:MehlingC CCC,
pubmed-author:MuellerSS,
pubmed-author:O'ConnellN CNC,
pubmed-author:RansomT PTP,
pubmed-author:SetchellK DKD,
pubmed-author:TeitelJ MJM,
pubmed-author:VidgenEE,
pubmed-author:WoleverT MTM
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1524-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9129487-Apolipoproteins B,
pubmed-meshheading:9129487-Bile Acids and Salts,
pubmed-meshheading:9129487-Cholesterol,
pubmed-meshheading:9129487-Cholesterol, HDL,
pubmed-meshheading:9129487-Cholesterol, LDL,
pubmed-meshheading:9129487-Cross-Over Studies,
pubmed-meshheading:9129487-Dietary Fats, Unsaturated,
pubmed-meshheading:9129487-Dietary Fiber,
pubmed-meshheading:9129487-Fatty Acids, Monounsaturated,
pubmed-meshheading:9129487-Feces,
pubmed-meshheading:9129487-Female,
pubmed-meshheading:9129487-Humans,
pubmed-meshheading:9129487-Hypercholesterolemia,
pubmed-meshheading:9129487-Male,
pubmed-meshheading:9129487-Middle Aged,
pubmed-meshheading:9129487-Psyllium
|
pubmed:year |
1997
|
pubmed:articleTitle |
Effect of psyllium in hypercholesterolemia at two monounsaturated fatty acid intakes.
|
pubmed:affiliation |
Clinical Nutrition and Risk Factor Modification Center, J Alick Little Core Lipid Laboratory, St Michael's Hospital, Toronto, Ontario, Canada. tina.perera@utoronto.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|